Mumbai, August 31, 2026: The Maharashtra Food and Drug Administration (FDA) has temporarily suspended the blood bank licence of Jagjivan Ram Hospital, Mumbai Central, for two days — October 15 and 16 — after finding 12 regulatory violations, including deficiencies in blood donation records, shortage of prescribed staff, inadequate documentation and lapses in storage and operational procedures.…
The clearance and broader-than-expected label for Mimrylo open up a yearly revenue opportunity for Takeda that some analysts expect to reach $2 billion or more.
An order issues by the Jammu and Kashmir FDA prohibited the sale, storage, distribution and display of 10 identified brands/batches of ghee across the Union Territory after laboratory analysis found…
